RO7812653
/ Roche
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
November 20, 2025
A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of RO7812653 in Participants With Early Symptomatic Alzheimer's Disease (eAD)
(clinicaltrials.gov)
- P1 | N=50 | Not yet recruiting | Sponsor: Hoffmann-La Roche
New P1 trial • Alzheimer's Disease • CNS Disorders
1 to 1
Of
1
Go to page
1